Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction
NCT04381351 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2020-05-27
Summary
In this study, critically ill patients with highly suspected or confirmed COVID-19 will be included. Main goal is the identification of noncoding RNAs in COVID-19 associated organ dysfunction with an emphasis on acute kidney injury.
Conditions
Sponsors & Collaborators
-
Heinrich-Heine University, Duesseldorf
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-16
- Primary Completion
- 2021-03-01
- Completion
- 2021-07-31
Countries
- Germany
Study Locations
More Related Trials
-
Kidney in Coronavirus Disease 2019 Registry
NCT04797091 ·Status: COMPLETED
-
Global Assessment of Acute and Chronic Kidney Disease Incidence and Outcomes in Patients With COVID-19 Infection
NCT04491227 ·Status: UNKNOWN
-
Acute Kidney Injury Risk in COVID-19
NCT04874779 ·Status: COMPLETED
-
Morphofunctional, Gene, Inflammation Molecules and Oxidative Stress Analysis in Kidney Tissue of COVID-19 Patients
NCT06444893 ·Status: COMPLETED
-
Immune Response Following COVID-19 in Hemodialysis Patients
NCT05307601 ·Status: COMPLETED
-
COVID-19 RELATED KIDNEY DAMAGE
NCT04706325 ·Status: UNKNOWN
-
Predict Adverse Events by Covid-19 Nephritis
NCT04347824 ·Status: COMPLETED
-
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury
NCT04445259 ·Status: UNKNOWN
-
Acute Kidney Dysfunction in COVID-19 and Non-COVID-19 Related ARDS
NCT05699889 ·Status: COMPLETED
-
Acute Kidney Injury Among COVID-19 Positive Patients
NCT04979195 ·Status: COMPLETED
-
Early Renal Replacement Therapy in COVID 19 Patients With AKI Does it Improve the Outcome?
NCT05274685 ·Status: COMPLETED ·Phase: NA
-
Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19)
NCT04393428 ·Status: COMPLETED
-
Serum circ_DLGAP4, lncRNA KCNQ1OT1, and Their Targets by Erythropoietin Resistance in Chronic Kidney Disease
NCT07037953 ·Status: COMPLETED
-
Emergency Department Management of Patients With Renal Infarction
NCT06515379 ·Status: COMPLETED
-
Kidney Disease After COVID-19
NCT05328986 ·Status: COMPLETED
-
The Effect of the Severity of COVID-19 Disease on the Incidence of Acute Renal Failure in ICU
NCT04799600 ·Status: COMPLETED
-
Renal Involvement in Hospitalized Children With COVID-19
NCT04788394 ·Status: COMPLETED
-
Renal Biomarkers in AKI and COVID-19
NCT04517630 ·Status: COMPLETED
-
Acute Kidney Injury in Patients Hospitalized With COVID-19
NCT04316299 ·Status: COMPLETED
-
Acute Kidney Injury in Critical COVID-19: Outcomes and Risks
NCT07089693 ·Status: COMPLETED
-
Reducing Acute Kidney Injury Occurence by Administering Angiotensin II
NCT05199493 ·Status: COMPLETED ·Phase: PHASE3
-
Patients With Acute Renal Failure During Severe COVID-19
NCT05077163 ·Status: UNKNOWN
-
Acute Kidney Injury and Renal Outcomes for COVID-19 Patients in Intensive Care Units
NCT04459975 ·Status: UNKNOWN
-
Circulating lncRNA and CV Morbidities in CKD and ESRD
NCT02304471 ·Status: UNKNOWN
-
Phenotyping Seroconversion Following Vaccination Against COVID-19 in Patients on Haemodialysis Study
NCT04815850 ·Status: COMPLETED